165 related articles for article (PubMed ID: 2495864)
1. Severe renal failure following high-dose ifosfamide and mesna.
Willemse PH; de Jong PE; Elema JD; Mulder NH
Cancer Chemother Pharmacol; 1989; 23(5):329-30. PubMed ID: 2495864
[TBL] [Abstract][Full Text] [Related]
2. Irreversible encephalopathy with ifosfamide/mesna.
Salloum E; Flamant F; Ghosn M; Taleb N; Akatchereian C
J Clin Oncol; 1987 Aug; 5(8):1303-4. PubMed ID: 3114437
[No Abstract] [Full Text] [Related]
3. Ifosfamide/mesna encephalopathy.
McCallum AK
Lancet; 1987 Apr; 1(8539):987. PubMed ID: 2882385
[No Abstract] [Full Text] [Related]
4. Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.
Steger GG; Dittrich C; Schlappack O; Mader R; Herold C; Brade WP; Keller A; Moser K
J Cancer Res Clin Oncol; 1988; 114(6):602-4. PubMed ID: 3144554
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.
Sutton GP; Blessing JA; Homesley HD; Berman ML; Malfetano J
J Clin Oncol; 1989 Nov; 7(11):1672-6. PubMed ID: 2509641
[TBL] [Abstract][Full Text] [Related]
6. Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results.
Willemse PH; vd Burg ME; vd Gaast A; Neijt JP; ten Bokkel Huinink WW; Aalders JG; de Vries EG
Cancer Chemother Pharmacol; 1990; 26 Suppl():S51-4. PubMed ID: 2112053
[TBL] [Abstract][Full Text] [Related]
7. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
[TBL] [Abstract][Full Text] [Related]
8. High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.
Sanchiz F; Milla A
Cancer Chemother Pharmacol; 1990; 26 Suppl():S91-2. PubMed ID: 2112057
[TBL] [Abstract][Full Text] [Related]
9. Encephalopathy with rapid infusion ifosfamide/mesna.
Perren TJ; Turner RC; Smith IE
Lancet; 1987 Feb; 1(8529):390-1. PubMed ID: 2880199
[No Abstract] [Full Text] [Related]
10. Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.
Husband DJ; Watkin SW
Lancet; 1988 May; 1(8594):1116. PubMed ID: 2896952
[No Abstract] [Full Text] [Related]
11. Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies.
Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
Cancer Chemother Pharmacol; 1990; 26 Suppl():S55-8. PubMed ID: 2112054
[TBL] [Abstract][Full Text] [Related]
12. Avoiding ifosfamide/mesna encephalopathy.
Meanwell CA; Kelly KA; Blackledge G
Lancet; 1986 Aug; 2(8503):406. PubMed ID: 2874408
[No Abstract] [Full Text] [Related]
13. High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.
Stuart-Harris RC; Harper PG; Parsons CA; Kaye SB; Mooney CA; Gowing NF; Wiltshaw E
Cancer Chemother Pharmacol; 1983; 11(2):69-72. PubMed ID: 6414732
[TBL] [Abstract][Full Text] [Related]
14. High-dose ifosfamide with mesna uroprotection: a phase I study.
Elias AD; Eder JP; Shea T; Begg CB; Frei E; Antman KH
J Clin Oncol; 1990 Jan; 8(1):170-8. PubMed ID: 2104923
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide/mesa and encephalopathy.
Cantwell BM; Harris AL
Lancet; 1985 Mar; 1(8431):752. PubMed ID: 2858016
[No Abstract] [Full Text] [Related]
16. Phase II trial with high-dose ifosfamide and mesna given in a 24-h infusion for advanced GI tract cancer.
Focan C; Boossy J; Focan-Henrard D; Reginster M; Claessens JJ
Cancer Chemother Pharmacol; 1989; 23(3):192-3. PubMed ID: 2493996
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
Matthiessen W; Stempinski E; Göbel D; Thalmann U
Cancer Treat Rev; 1983 Sep; 10 Suppl A():121-3. PubMed ID: 6414688
[No Abstract] [Full Text] [Related]
18. Ifosfamide, mesna, and encephalopathy.
Lancet; 1985 Jun; 1(8442):1398-9. PubMed ID: 2861351
[No Abstract] [Full Text] [Related]
19. Dosing and side-effects of ifosfamide plus mesna.
Brade WP; Herdrich K; Kachel-Fischer U; Araujo CE
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S164-86. PubMed ID: 1795007
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide/mesna and hematuria.
Pratt CB; Goren MP
Cancer Treat Rep; 1987 Nov; 71(11):1124-5. PubMed ID: 3119210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
